NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

Imo FlaskWorks is a strategic asset that has the potential to bring in significant revenues and/or be a lever for reducing manufacturing costs.

I would be careful in how this asset is valued and treated.

Nwbo got the IP with FlaskWorks, and aside from using the technology/process for DCVax manufacturing cost, speed, consistency and quality, Advent could be set up to manufacture for other cellular products, or licensing of the applications of the IP is another option that isn’t mutually exclusive.

Imo, in no event should nwbo management make moves to preclude nwbo’s use nor lose out on at least a share of any derived revenues, and in the case the technology is in effect sold or separated from nwbo, there better be an appropriate valuation and consistent compensation to nwbo in the full interests of the company and its shareholders!!!

Any shenanigans with this asset would anger me and I assume a great many shareholders who have been so supportive for all those years where survival of nwbo was an ever present concern.